Fig. 2From: The prognostic impact of GSTM1/GSTP1 genetic variants in bladder CancerDistribution of the GSTM1 + GSTP1 variants in bladder cancer patients. The distribution of patients carrying GSTM1 null and GSTP1 recessive homozygote/ heterozygote AG/GG was 23 of 93 (24.73%). whereas the lowest was GSTM1 null and the GSTP1 wild allele 14 (15.05%)Back to article page